Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Quisovalimab by Avalo Therapeutics for Asthma: Likelihood of Approval
Quisovalimab is under clinical development by Avalo Therapeutics and currently in Phase II for Asthma. According to GlobalData, Phase II...
Quisovalimab by Avalo Therapeutics for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Quisovalimab is under clinical development by Avalo Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Quisovalimab by Avalo Therapeutics for Asthma: Likelihood of Approval
Quisovalimab is under clinical development by Avalo Therapeutics and currently in Phase II for Asthma. According to GlobalData, Phase II...